AT

Allyson Tighe

CEO at Stereo Biotherapeutics

Vancouver, British Columbia

Investor
VC

Invests in

Stages:

Series A
Seed

Locations:

Vancouver, BC

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Strategy
Business Development
Commercialization
Lifesciences
Neuroscience
Market Research
Project Management
Business Strategy
Research
Clinical Research
Life Sciences
Competitive Intelligence
Entrepreneurship
Pharmaceutical Industry
Cell Biology
Start-ups
Biotechnology
Competitive Analysis
Data Analysis
Mergers & Acquisitions

Education

Lists including Allyson

AT
AS
AT
AH

All Series A Investors

14748 people

AM
AT
AS
AR

All Seed Investors

19691 people

Investments

Tentarix Biotherapeutics

Series B

Total Funding: $85M

Work Experience

SB
Stereo Biotherapeutics

2024

  • Chief Executive Officer

    2024

AV
Amplitude Ventures

2018 - 2024

  • Co-founder and Investor

    2018 - 2024

TB
Tentarix Biotherapeutics

2023 - 2024

  • Board Director

    2023 - 2024

TU
The University of British Columbia

2021 - 2024

  • Adjunct Professor

    2021 - 2024

AT
Abdera Therapeutics

2021 - 2023

  • Board Observer

    2021 - 2023

B
BDC

2016 - 2018

  • Healthcare Venture Fund

    2016 - 2018

The Centre for Drug Research & Development (CDRD)

2015 - 2016

  • Business Development Manager

    2015 - 2016